• Arylsulfatase A (ARSA) Mutation Analysis, Molecular Methods
  • Hyperplasia of ovarian stroma
  • EsoGuard Methylation Assay for Barrett’s Esophagus
  • 22q11.2 microdeletion (DiGeorge) syndrome
  • Electrolyte Panel, Urine
  • Thyroxine, Free (FT4)
  • FLT3 (FMS-related Tyrosine Kinase 3) Mutation Analysis, Blood
  • Occult Blood, Fecal, Immunochemical Testing (iFOB)
  • Methlyenetetrahydrofolate reductase (MTHFR) Mutation Analysis
  • Amiodarone, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Avantect Pancreatic Cancer Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Avantect Pancreatic Cancer Test
Medical Test

Interpretation
Access to Avantect Pancreatic Cancer Test is restricted.